quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 21, 2026

Netflix (NFLX) Q4 2025 Earnings Call Transcript

View original at nasdaq.com
Netflix (NFLX) Q4 2025 Earnings Call Transcript Image source: The Motley Fool. Date Tuesday, Jan. 20, 2026 at 4:45 p.m…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Netflix will add 2+ live operation centers in 2026 in UK and Asia

    80% confidence
  • The Warner Bros. deal is pro-consumer, pro-innovation, pro-worker, pro-creator, and pro-growth

    80% confidence
  • Total Netflix view hours grew 2% year-over-year in 2025, adding 1.5 billion hours, accelerating from 1% in prior year

    80% confidence
  • Q2 2024 operating margin expanded 5 percentage points year-over-year

    80% confidence
  • Netflix targets 2026 operating margin of 31.5%, up 2 percentage points including 0.5 point M&A expense headwind

    80% confidence
  • Ad-supported ARM is currently below ad-free ARM, representing a monetization gap

    80% confidence
  • Netflix 2025 operating margin reached 26%, raised from 25% guidance

    80% confidence
  • 2026 operating margin will be 2.5 points higher excluding M&A expenses

    80% confidence
  • Netflix expects content amortization to increase 10% year-over-year in 2026

    80% confidence
  • Netflix historically expanded operating margin by approximately 2 percentage points annually on average

    80% confidence
  • Netflix primary quality metric reached all-time high in 2025

    80% confidence
  • There are 500+ million smart TV households globally that are non-Netflix members

    80% confidence
  • Netflix has less than 10% of TV time in all major markets

    80% confidence
  • Q2 2024 revenue growth was 17% reported

    80% confidence
  • Gaming market size is approximately $140 billion in consumer spend excluding China

    80% confidence
  • The Warner Bros. acquisition represents a tremendous, very achievable opportunity

    80% confidence
  • Netflix tested vertical video for approximately 6 months

    80% confidence
  • Modular interactive video ads with dynamic templates completed testing in late 2025 with global rollout in 2026

    80% confidence
  • M&A expenses will create half a percentage point drag on operating margin in 2026

    80% confidence
  • Netflix forecasts 2026 revenue of $51 billion, representing 14% year-over-year growth

    80% confidence
  • Post-acquisition, 85% of Netflix revenue will come from current core businesses

    80% confidence
  • India ranked #2 and #3 for Netflix paid net adds and revenue growth in Q2 2024

    80% confidence
  • Customer satisfaction reached all-time high

    80% confidence
  • Netflix will maintain 45-day theatrical window post-Warner Bros. acquisition

    80% confidence
  • Netflix will spend $17 billion on content cash in 2026, growing slower than revenue

    80% confidence
  • Branded originals viewing grew 9% year-over-year in H2 2025 and 7% in H1 2025, representing approximately 50% of total viewing

    80% confidence
  • Q2 2024 had strong acquisition and healthy retention across all regions

    80% confidence
  • Netflix content cash-to-expense ratio is 1.1x

    80% confidence
  • Netflix expects approximately $6 billion in free cash flow for 2026

    80% confidence
  • Japanese consumers watch 50-67% less TV than US consumers

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Netflix (NFLX) Q4 2025 Earnings Call Transcript — Source | Via News | pt.VIA.NEWS